Add Company
Join Now

REDX Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Real Estate

Industry

Estimated Revenue & Valuation

  • REDX's estimated annual revenue is currently $20.3M per year.(i)
  • REDX's estimated revenue per employee is $150,000

Employee Data

  • REDX has 135 Employees.(i)

REDX's People

NameTitleEmail/Phone
1
Co-Founder & CEOReveal Email/Phone
2
VP TechnologyReveal Email/Phone
3
VP SalesReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
Data ScientistReveal Email/Phone
6
Data ScientistReveal Email/Phone
7
Affiliate Marketing ManagerReveal Email/Phone
8
Video Production ManagerReveal Email/Phone
9
Marketing ManagerReveal Email/Phone
10
Customer Success RepresentativeReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.6M50N/AN/AN/A
#2
$34.3M2089%N/AN/A
#3
$6040M300395%$1.5B$3.3B
#4
$59.6M318N/AN/AN/A
#5
$4.6M40N/AN/AN/A
#6
$87.8M468N/AN/AN/A
#7
$39.2M246N/AN/AN/A
#8
$83.6M44660%N/AN/A
#9
$4M36N/AN/AN/A
#10
$7.6M56N/AN/AN/A
#11
$0.9M10N/AN/AN/A
#12
$15.9M106N/AN/AN/A
#13
$3.9M34N/AN/AN/A
#14
$3.6M31N/AN/AN/A
#15
$0.1M8-27%$7.4MN/A
#16
$27.3M17112%N/AN/A
#17
$23.2M154-4%$80.9MN/A
#18
$3.5M20N/AN/AN/A
#19
$6.9M53N/AN/AN/A
#20
$0.5M176%$52.1MN/A
Add Company

What Is REDX?

keywords:N/A

N/A

Total Funding

135

Number of Employees

$20.3M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

REDX News

2022-04-17 - City Looking At Boosting Demolition Budget To $1M ...

City leaders noted that Wheeling's Red X program had put pressure on owners to address their dilapidated properties, and also let others in...

2022-04-17 - City Looking At Boosting Demolition Budget To $1M ...

City leaders noted that Wheeling's Red X program had put pressure on owners to address their dilapidated properties, and also let others in...

2022-04-13 - Redx Pharma Says RXC004 is Being Evaluated as a Monotherapy in Phase 2 Clinical Trials

Redx Pharma PLC said late on Friday that its RXC004 cancer drug was being evaluated as a monotherapy in Phase 2 proof-of-concept clinical...

2022-04-13 - Redx Pharma Says RXC004 is Being Evaluated as a Monotherapy in Phase 2 Clinical Trials

Redx Pharma PLC said late on Friday that its RXC004 cancer drug was being evaluated as a monotherapy in Phase 2 proof-of-concept clinical...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$39.4M13620%N/A
#2
$20M13810%$36M
#3
$20.7M14810%N/A
#4
$24.2M152N/AN/A
#5
$44.2M160-2%N/A